Today: 9 July 2026
Browse Category

Earnings Reports 6 May 2026

Coupang Stock Slides After $266 Million Q1 Loss, and the Data-Breach Bill Is Still Coming Due

Coupang Stock Slides After $266 Million Q1 Loss, and the Data-Breach Bill Is Still Coming Due

Coupang Inc. shares took a 16.6% hit to $17.32 in early afternoon trading in New York on Wednesday, pressured by a $266 million net loss for the first quarter. The South Korea-focused e-commerce company blamed higher compensation and network expenses stemming from last year’s data breach for the red ink in the January–March stretch. MarketScreener provided the trading data.
6 May 2026
····
SolarEdge Stock Slides After Earnings Miss as Turnaround Faces a Harder Test

SolarEdge Stock Slides After Earnings Miss as Turnaround Faces a Harder Test

Shares of SolarEdge Technologies slipped roughly 6% by late Wednesday morning. The solar-equipment firm posted a deeper adjusted first-quarter loss than Wall Street had braced for, even as sales came in ahead of estimates and guidance pointed to near-breakeven operations next quarter. SolarEdge was changing hands at $41.91, having dipped to $37.83 earlier in the session.
6 May 2026
··
Palantir Stock Just Sank After a Blowout Quarter. Wall Street Is Finding the One Thing It Didn’t Like

Palantir Stock Just Sank After a Blowout Quarter. Wall Street Is Finding the One Thing It Didn’t Like

Palantir Technologies shares dropped 1.4% to $134.04 late Wednesday morning, deepening a selloff that’s followed its recent earnings release. That’s even with the data analytics and AI software firm delivering its strongest revenue growth yet as a public company and upping its full-year forecast. The stock finished Tuesday at $135.91.
6 May 2026
···
Arm Stock Surges Before Earnings as AI Server CPU Bet Faces Wall Street Test

Arm Stock Surges Before Earnings as AI Server CPU Bet Faces Wall Street Test

Arm Holdings plc’s U.S. shares jumped $22.58 to hit $231.42 in New York morning trading Wednesday, up roughly 11%, ahead of the British chip designer’s fiscal fourth-quarter report due after the bell. The rally pushed Arm squarely into focus again for the AI-chip trade, which has shifted recently from graphics chips over to server CPUs.
6 May 2026
····
Nebius Stock Near Record High After $643 Million Eigen AI Deal — Q1 Earnings Could Decide The Next Move

Nebius Stock Near Record High After $643 Million Eigen AI Deal — Q1 Earnings Could Decide The Next Move

Nebius Group shares hovered close to record highs Wednesday, with the Amsterdam-based AI cloud firm announcing plans to acquire Eigen AI. Investors appear to be watching this deal as a sign of Nebius’s push from leasing out hard-to-find computing power into selling higher-margin software. The Nasdaq-listed shares last changed hands at $175.92, just shy of the all-time closing peak set Monday at $176.42.
6 May 2026
··
1 … 19 20 21 22 23 … 262

Stock Market Today

  • Virax Biolabs Signs Exclusive Supply Pact With Fosun Diagnostics for Southeast Asia
    July 9, 2026, 8:49 AM EDT. Virax Biolabs Group Limited (NASDAQ: VRAX) has landed an exclusive commercial supply deal with Fosun Diagnostics to cover six Southeast Asian countries: Thailand, Vietnam, Indonesia, the Philippines, Singapore, and Malaysia. The agreement is for Virax's ImmuneSelect immune profiling products, separate from its diagnostic platform that's still in the works. Virax can now supply products right away through purchase orders, eyeing near-term revenue and a wider regional presence. Fosun Diagnostics, under Fosun Pharma, will use its network for distribution across the region. The agreement leaves room for more products, higher volume, and the chance of OEM or private-label deals down the line. Pricing is set up for scale. The deal moves Virax further into the ASEAN diagnostics market.
Go toTop